Unlocking Cancer Therapy’s Enigma: Lysosomal Reservoirs Dictate PARP Inhibitor Efficacy in Ovarian Tumors
The persistent enigma of cancer therapy—why a single drug can be a life-saving breakthrough for...
Knowledge and News for the Global Fight Against Cancer.
The persistent enigma of cancer therapy—why a single drug can be a life-saving breakthrough for...
Scribe Therapeutics, a pioneering startup focused on advanced gene editing medicines, successfully priced its initial...
The global healthcare landscape is currently facing an unprecedented challenge as aging populations contribute to...
In the traditional understanding of oncology, tumor suppressor genes and DNA repair proteins are categorized...
The diagnosis of pediatric cancer remains one of the most challenging experiences a family can...
The second annual Walk by Faith Gala, hosted by the Maddy Nelson Memorial Foundation, recently...
CureSearch for Children’s Cancer, a leading national non-profit organization dedicated to accelerating the development of...
The scientific community mourns the loss of Susumu Tonegawa, PhD, a towering figure in molecular...
Immunotherapy has emerged as a transformative force in cancer treatment, offering new hope for patients...
Researchers from Weill Cornell Medicine and the Massachusetts Institute of Technology have made a pivotal...